贵州大秦肿瘤医院有限公司
Search documents
贵州赤天化股份有限公司关于提供担保的进展公告
Shang Hai Zheng Quan Bao· 2025-07-31 19:14
Core Viewpoint - The announcement details the progress of guarantees provided by Guizhou Chitianhua Co., Ltd. for its wholly-owned subsidiaries, Guizhou Daqin Tumor Hospital Co., Ltd. and Guizhou Chitianhua Tongzi Chemical Co., Ltd., including specific amounts and terms of the guarantees [1][2][3]. Summary by Sections Guarantee Overview - The company has approved a total guarantee limit of up to 1.8 billion RMB for its subsidiaries in 2025, which includes the renewal of existing guarantees [2][3]. - The company has provided a guarantee of 24.46 million RMB to Daqin Hospital and 70 million RMB to Tongzi Chemical as of July 31, 2025 [1][2]. Details of the Guaranteed Entities - Guizhou Daqin Tumor Hospital has total assets of 1.16 billion RMB and liabilities of 807.86 million RMB as of March 31, 2025, with a net loss of 2.98 million RMB in Q1 2025 [5]. - Guizhou Chitianhua Tongzi Chemical has total assets of 272.82 million RMB and liabilities of 117.26 million RMB as of March 31, 2025, with a net profit of 1.38 million RMB in Q1 2025 [7]. Guarantee Agreements - The company has entered into a guarantee agreement with China Agricultural Development Bank for Daqin Hospital, covering a principal amount of 650 million RMB [9][10]. - A separate guarantee agreement with Guizhou Bank for Tongzi Chemical covers a principal amount of 840 million RMB [11][12]. Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary for supporting the subsidiaries' project construction and daily operations, with the company maintaining effective control over the subsidiaries' operational risks [14]. - The total external guarantees amount to 1.15 billion RMB, representing 45.34% of the company's latest audited net assets [15].
证券代码:600227 证券简称:赤天化 编号:2025-048
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-06-30 23:11
Summary of Key Points Core Viewpoint The company has approved guarantees for its wholly-owned subsidiaries, Guizhou Daqin Tumor Hospital Co., Ltd. and Guizhou Chitianhua Tongzi Chemical Co., Ltd., to support their financing needs, with a total guarantee limit set for the year 2025. Group 1: Guarantee Overview - The company has approved a total guarantee amount of up to 1.8 billion yuan for its subsidiaries in 2025, including a maximum of 600 million yuan for third-party guarantees [1][2] - As of June 30, 2025, the total external guarantees provided by the company and its subsidiaries amount to 1.1702844 billion yuan, which is 45.99% of the company's latest audited net assets [1][15] - There are no overdue guarantees as of the announcement date [1][15] Group 2: Details of the Guaranteed Subsidiaries - Guizhou Daqin Tumor Hospital Co., Ltd. has total assets of 1.16916789 billion yuan and liabilities of 807.8614 million yuan as of March 31, 2025, with a net loss of 29.8208 million yuan in Q1 2025 [4][3] - Guizhou Chitianhua Tongzi Chemical Co., Ltd. has total assets of 2.7281658 billion yuan and liabilities of 1.1726276 billion yuan as of March 31, 2025, with a net profit of 1.37773 million yuan in Q1 2025 [6][5] Group 3: Guarantee Agreements - The company has entered into a guarantee agreement with Guizhou Bank for a loan of 30 million yuan to Guizhou Daqin Tumor Hospital, with a guarantee period of three years from the loan's maturity [7][6] - For Guizhou Chitianhua Tongzi Chemical, the company has provided guarantees for multiple loans, including a maximum of 145 million yuan for various financing needs, with similar guarantee terms [10][9] - The guarantees cover all principal, interest, penalties, and related costs incurred in the event of default [11][10]
赤天化: 贵州赤天化股份有限公司关于向关联方支付担保费暨关联交易的补充公告
Zheng Quan Zhi Xing· 2025-05-09 09:48
Overview - The company announced a supplementary notice regarding the payment of guarantee fees to related parties and the associated transactions [1] Transaction Details - The board of directors approved a proposal for the company to pay guarantee fees to related parties, which will be submitted for review at the 2024 annual general meeting [1] - The company’s wholly-owned subsidiary, Guizhou Daqin Tumor Hospital Co., Ltd., will receive a fixed asset loan from the Agricultural Development Bank of China, with guarantees provided by Guizhou Chitianhua Group and Zunyi Tiantong Plastic Co., Ltd. [1] - The guarantee fee payment is based on the assessed value of the collateral provided for the loan [2] Asset Evaluation - The assessed value of the collateral, which includes 66 properties and commercial spaces, is determined to be 200.8363 million yuan, reflecting a decrease of 22.23% from the previous bank assessment [2] - The decline in assessed value is attributed to reduced usable life of the assets and a sluggish real estate market [2] Adjusted Guarantee Fee Structure - The pricing basis for the guarantee fee will be adjusted according to the new assessed value [3] - The maximum estimated total guarantee fee is now capped at 34.6443 million yuan, calculated based on the new assessed value over a maximum period of 11.5 years [5] Future Implications - The adjustment in the assessed value of the collateral will lead to a reduction in the guarantee fees payable by the company [5] - The company aims to negotiate with the Agricultural Development Bank to release the guarantees by 2028, contingent on the hospital's operational performance [5]